Tojsiab
Johnson & Johnson tus mob coronavirus koob tshuaj tiv thaiv Tam sim no tsuas yog tso cai rau cov neeg laus hauv Asmeskas uas tsis tuaj yeem tau txais lwm yam tshuaj tiv thaiv, Food and Drug Administration tshaj tawm hnub Thursday, hais txog cov tshuaj tiv thaiv Johnson & Johnson qhov kev pheej hmoo ntawm kev phom sij rau lub neej uas cuam tshuam txog ntshav txhaws.
Ib tug poj niam sau lub koob txhaj tshuaj nrog Johnson & Johnson's Covid-19 tshuaj tiv thaiv.
SANDER KONING/ANP/AFP ntawm Getty Images
Cov Lus Tseem Ceeb
Vim tias cov tshuaj tiv thaiv muaj feem yuav ua rau mob thrombosis nrog thrombocytopenia Syndrome (TTS), cov ntshav txhaws uas tuaj yeem ua rau mob stroke lossis plawv nres, nws yuav tsum tsis txhob siv tshwj tsis yog lwm cov tshuaj tiv thaiv tsis muaj lossis txiav txim siab tsis tsim nyog, FDA hais tias.
TTS tsis tshua muaj, cuam tshuam txog 1 tus neeg hauv 250,000 leej twg txhaj tshuaj tiv thaiv Johnson & Johnson, tab sis nws yog qhov hnyav dua li qhov feem ntau mob plawv mob qee zaum cuam tshuam nrog Pfizer thiab Moderna cov tshuaj tiv thaiv Covid-19.
Johnson & Johnson cov tshuaj tiv thaiv kuj tau txuas rau qee yam tsis tshua muaj Guillain-Barré mob-Ib qho kev tiv thaiv kab mob uas tuaj yeem ua rau tuag tes tuag taw-txawm tias FDA tsis tau hais txog qhov no hauv nws qhov kev txiav txim siab kom nqaim cov tshuaj tiv thaiv kev tso cai.
Johnson & Johnson cov tshuaj tiv thaiv tseem muaj lub luag haujlwm hauv cov lus teb thoob ntiaj teb, thiab qhov kev txiav txim siab txo qis nws qhov kev tso cai qhia tau meej meej ntawm FDA cov kab ke kev nyab xeeb, hais tias Dr. daim ntawv qhia.
Hauv kev teb rau qhov kev txiav txim siab, Johnson & Johnson tau hais tias nws tau hloov kho nws cov tshuaj tiv thaiv daim ntawv qhia tseeb txhawm rau txhawm rau paub txog cov kev mob tshwm sim ntawm cov ntshav txhaws, tab sis tau taw qhia tias cov ntaub ntawv muaj nyob txuas ntxiv qhia tias tau txais cov tshuaj tiv thaiv Johnson & Johnson muaj kev nyab xeeb dua li tsis muaj tshuaj tiv thaiv.
Tus Keeb Kwm Tseem Ceeb
Pfizer thiab Moderna cov tshuaj tiv thaiv Covid-19 ua haujlwm los ntawm kev xa ib daim ntawm tus xa xov RNA (mRNA) uas qhia cov hlwb los tsim cov kab mob coronavirus tsis zoo, tsim kom muaj kev tiv thaiv kab mob tiv thaiv tus kabmob coronavirus. Hauv qhov sib piv, cov tshuaj tiv thaiv Johnson & Johnson muab cov lus qhia los tsim kev tiv thaiv-tsim tus kabmob coronavirus siv cov tshuaj tiv thaiv kabmob. mob khaub thuas uas tau ua tsis raug mob thiab tsis muaj peev xwm rov tsim dua. Txij li thaum nws yog tso cai rau kev siv thaum muaj xwm txheej ceev thaum Lub Ob Hlis 2021, Johnson & Johnson cov tshuaj tiv thaiv tau pom tias muaj txiaj ntsig tsawg dua li Pfizer thiab Moderna cov tshuaj tiv thaiv. Feem ntau cov kev sim tshuaj tau pom Johnson & Johnson cov tshuaj tiv thaiv nyob ib puag ncig 68% zoo ntawm kev tiv thaiv tsev kho mob los ntawm Covid-19, deb tsawg tshaj qhov sib tw tshuaj tiv thaiv. Thaum Lub Peb Hlis, Lub Chaw Tiv Thaiv thiab Tiv Thaiv Kab Mob pom zoo hais tias cov neeg uas tau kawm txog Johnson & Johnson cov tshuaj tiv thaiv tau txais ib qho tshuaj tiv thaiv los ntawm Pfizer lossis Moderna, uas tuaj yeem tsim lub cev tiv thaiv kab mob thiab txo qis kev pheej hmoo ntawm TTS.
Contra
CDC txuas ntxiv mus pom zoo kom Johnson & Johnson cov tshuaj tiv thaiv rau txhua tus neeg uas muaj qhov tshwm sim hnyav tom qab txhaj tshuaj tiv thaiv mRNA lossis leej twg yuav tsis txhaj tshuaj tiv thaiv vim muaj kev txwv rau lwm cov tshuaj tiv thaiv.
ntxiv nyeem ntawv
Tau qhov twg los: https://www.forbes.com/sites/zacharysmith/2022/05/05/fda-limits-use-of-johnson-johnson-vaccine-due-to-blood-clot-risk/